EP4147053
ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
7.5.2021EP published:
28.1.2026EP application number:
21723277.6
EPO information:
European Patent Register
Max expiry date:
6.5.2041Expiry date:
27.5.2026
Title in English:
ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPYLanguage of the patent:
English
Timeline
Today
7.5.2021EP application
28.1.2026EP Publication
27.5.2026Expires
Owner
Name:
Institut CurieAddress:
26, rue d'Ulm, 75248 Paris Cedex 05, FR
Name:
Institut National de la Santé et de la Recherche Médicale (INSERM)Address:
101 rue de Tolbiac, 75013 Paris, FR
Inventor
Name:
MECHTA-GRIGORIOU, FatimaAddress:
94100 SAINT MAUR DES FOSSES, FR
Name:
KIEFFER, YannAddress:
94700 MAISONS-ALFORT, FR
Name:
VINCENT-SALOMON, AnneAddress:
75013 PARIS, FR
Name:
HOCINE, Rachid, HocineAddress:
MANHATTAN, NEW YORK 10021, US
Priority
Number:
20305454Date:
7.5.2020Country:
EP
Classification
Categories:
G01N 33/574, C07K 16/00